[1]
T. Sirotkin, A. Natour, O. Wand, and Y. Levy, “Fatal consequences of therapeutic thoracentesis in patients with systemic sclerosis”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 37, no. 3, p. e2020006, Sep. 2020, doi: 10.36141/svdld.v37i3.9567.